Similar articles

• An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.

  Kassa J, Karasova J, Musilek K, Kuca K, Bajgar J. Kassa J, et al. Clin Toxicol (Phila). 2009 Jan;47(1):72-6. doi: 10.1080/15563650802043652. Clin Toxicol (Phila). 2009. PMID: 18686075
• [Cholinesterase reactivators--a new class of pharmacological substances].

  Golikov SN, Zaugol'nikov SD, Nikulina LP, Rybolovlev RS, Shchekoldina VI, Dovzhenko IG. Golikov SN, et al. Vestn Akad Med Nauk SSSR. 1966;21(5):3-8. Vestn Akad Med Nauk SSSR. 1966. PMID: 5984675 Russian. No abstract available.
• Blood-brain barrier permeability in various parts of the central nervous system.

  Aarseth P, Barstad JA. Aarseth P, et al. Arch Int Pharmacodyn Ther. 1968 Dec;176(2):434-42. Arch Int Pharmacodyn Ther. 1968. PMID: 5715414 No abstract available.
• Current understanding of the application of pyridinium oximes as cholinesterase reactivators in treatment of organophosphate poisoning.

  Jokanović M, Stojiljković MP. Jokanović M, et al. Eur J Pharmacol. 2006 Dec 28;553(1-3):10-7. doi: 10.1016/j.ejphar.2006.09.054. Epub 2006 Oct 11. Eur J Pharmacol. 2006. PMID: 17109842 Review.
• [Acetylcholinesterase. Function, inhibition and reactivation].

  Wassermann O. Wassermann O. Pharmazie. 1968 Feb;23(2):49-56. Pharmazie. 1968. PMID: 4877688 Review. German. No abstract available.